相关实验视频

Updated: Jul 23, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

骨形态遗传蛋白13对体外肝细胞癌细胞具有原生源性影响

Vanessa Kersten¹, Tatjana Seitz¹, Judith Sommer¹

¹Institute of Biochemistry, Friedrich-Alexander-University Erlangen-Nürnberg, D-91054 Erlangen, Germany.

International journal of molecular sciences

|July 14, 2023

概括

由激活的肝星细胞 (HSC) 分泌的骨形基因蛋白13 (BMP13),通过刺激HCC细胞增殖,促进肝细胞癌 (HCC) 的进展. 这项研究确定了BMP13作为HCC治疗的潜在治疗标.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
分子生物学分子生物学

背景情况:

激活的肝星细胞 (HSC) 在肝纤维化和肝癌发生过程中至关重要.
肝细胞细胞促进肝细胞癌 (HCC) 的进展,但潜在的机制尚未完全理解.
骨形态遗传蛋白13 (BMP13) 是最近在纤维化肝脏组织内的HSC中发现的.

研究的目的:

研究肝细胞癌 (HCC) 中BMP13的表达和功能.
确定HCC中BMP13的细胞源和信号通路.
评估向BMP13在HCC中的治疗潜力.

主要方法:

在人类HSC和HCC细胞系中分析BMP13的表达.
免疫光染色以确认BMP13和α-平滑肌动蛋白 (α-SMA) 在HCC组织中的同位.
用重组BMP13刺激HCC细胞,并评估下游信号 (SMAD,ERK) 和基因表达 (ID1,ID2,CDKN1A,CDKN2A).
在体外增殖和克隆性测试.
使用ALK2/3抑制剂dorsomorphin 1 (DMH1) 的抑制研究.

主要成果:

在激活的人类HSC中发现了高BMP13表达,与α-SMA相关,但不在HCC细胞系中.
BMP13刺激HCC细胞增加了细胞增殖,殖民地形成和细胞循环促进剂ID1/ID2.2.的表达.
BMP13信号传递涉及SMAD和ERK的酸化和细胞循环抑制剂CDKN1A/CDKN2A.A.的减少表达.
BMP13的原始原生效应被DMH1阻断,表明通过ALK2/3受体作用.

结论:

斯特罗玛衍生的BMP13作为肝细胞癌 (HCC) 的新瘤促进剂.
通过特定的分子通路,BMP13信号增强了HCC细胞的增殖.
BMP13代表了HCC治疗的潜在新疗法标.

关键词:

在BMP13中,BMP13是最重要的.肝脏的恒星细胞.肝细胞癌是肝细胞癌.

更多相关视频

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties

Published on: August 7, 2020

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...